Merck has invested more than €290 million in its biosafety testing capacity at Rockville, Maryland, in the US.   The company says the investment will significantly increase the company’s ability to conduct biosafety testing and analytical development services, critical to the drug development and commercialisation process.  “These significant investments in Rockville and other sites across our […]